The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (NASDAQ:CGABL) Short Interest Up 315.0% in July

The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (NASDAQ:CGABL) was the target of a large growth in short interest in the month of July. As of July 31st, there was short interest totalling 8,300 shares, a growth of 315.0% from the July 15th total of 2,000 shares. Based on an average daily volume of 21,200 shares, the days-to-cover ratio is currently 0.4 days.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Stock Performance

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 stock traded down $0.18 during midday trading on Monday, hitting $18.43. 7,555 shares of the company were exchanged, compared to its average volume of 21,128. The company’s fifty day moving average price is $18.36 and its 200-day moving average price is $18.89. Carlyle Group Inc. 4.625% Subordinated Notes due 2061 has a fifty-two week low of $15.60 and a fifty-two week high of $20.75.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, August 15th. Shareholders of record on Thursday, August 1st will be given a $0.2891 dividend. This represents a $1.16 dividend on an annualized basis and a dividend yield of 6.27%. The ex-dividend date is Thursday, August 1st.

About Carlyle Group Inc. 4.625% Subordinated Notes due 2061

biohaven is engaged in the identification and development of clinical stage compounds targeting the glutamatergic system. biohaven obtained licenses from yale university school of medicine and massachusetts general hospital regarding intellectual property relating to the use of certain glutamate modulating agents in the treatment of neuropsychiatric disorders.